BUSINESS● LOWSep 20 · Sep 20, 2026, 4:00 AM
Novo investors call for dealmaking and new drugs
Financial Times · global
Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS25m agoJohnson Controls International Q4 2026 Earnings PreviewSeeking Alpha TechBUSINESS25m agoHSBC Holdings Q3 2026 Earnings PreviewSeeking Alpha Tech